Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

Lung Fibrosis is a progressive, life-limiting condition that causes scarring of the lungs, making breathing increasingly ...

Compared with chemotherapy alone, neoadjuvant nivolumab plus chemotherapy extends overall survival in patients with resectable non-small cell lung cancer.

The study also revealed correlations between breathing patterns and physical and mental health, including anxiety and ...

Kentucky, still vastly reliant on fossil fuel-fired power plants, has much at stake in the EPA's power plant rulemaking.

Three years ago, before I learned that I had metastatic cancer, doctors repeatedly told me I was “too young” to be seriously ...

With the new school year set to begin on June 16, public health advocates and child protection groups are calling on the ...

Ibtrozi had a 90% response rate in treatment naïve adults with locally advanced or metastatic ROS1-positive non-small cell ...

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...

This weekend is graduation at Stanford. The keynote for Saturday’s medical school ceremony is a Stanford doctor, professor and now patient. Dr. Bryant Lin is fighting stage four lung cancer.

The Barbara Ann Karmanos Cancer Institute's Office of Community Outreach and Engagement (COE) continues the 2025 Community ...

The timing of immunotherapy initiation is not a significant factor in the outcomes of patients with extensive-stage small ...